David Hung

David Hung’s Nuvation Bio seals merger with blank check firm Panacea
Pharmaforum
Wed, 10/21/20 - 10:40 am
Nuvation Bio
David Hung
cancer
Panacea
SPAC
With Ex-Medivation Exec Hung at Helm, Nuvation Nabs $275M for Cancer
Xconomy
Mon, 10/28/19 - 10:49 am
David Hung
oncology
startups
R&D
Nuvation Bio
The stint that never happened? Biotech vet David Hung wipes Axovant from his work history
Stat
Tue, 04/10/18 - 10:20 pm
David Hung
Axovant
David Hung makes a quick, abrupt exit at Axovant after humiliating setbacks
Endpoints
Mon, 02/12/18 - 09:11 am
David Hung
Axovant
The billion-dollar gamble: Biotech CEO takes a risky second shot at an Alzheimer’s drug
Stat
Thu, 09/7/17 - 09:35 am
Alzheimer's disease
Axovant
David Hung
dimebon
Medivation
intepirdine
3 Small Biotech Stocks Being Run by Proven Winners
Motley Fool
Mon, 07/17/17 - 11:15 am
biotech
Axovant
Esperion Therapeutics
Aurinia Pharmaceuticals
Richard Glickman
David Hung
Roger Newton
A company developing a drug to treat Alzheimer's disease just got a new CEO — and the stock is jumping
Yahoo/Business Insider
Mon, 04/10/17 - 10:12 pm
Alzheimer's disease
David Hung
Pharma CEOs
Axovant Sciences
The Best Biopharma CEOs of 2016 Are...
TheStreet.com
Mon, 12/19/16 - 11:56 am
Pharma CEOs
Ken Frazier
Merck
David Hung
Medivation
Scott Jackson
Celator Pharmaceuticals
Ed Kaye
Sarepta Therapeutics
Mike Morrissey
Exelixis
$354M exit package in hand, Medivation CEO David Hung completes a master class in biotech auctions
Endpoints
Wed, 08/31/16 - 09:09 pm
Medivation
Pfizer
David Hung
M&A
executive pay